Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus

被引：0
|
作者：
Yoshiki Kusunoki
Tomoyuki Katsuno
Kana Miyakoshi
Takashi Ikawa
Rie Nakae
Fumihiro Ochi
Masaru Tokuda
Takafumi Akagami
Kazuki Murai
Masayuki Miuchi
Tomoya Hamaguchi
Jun-ichiro Miyagawa
Mitsuyoshi Namba
机构：
[1] Hyogo College of Medicine,Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine
[2] Hyogo College of Medicine,Innovative Diabetes Treatment
来源：
Diabetes Therapy | 2013年 / 4卷
关键词：
Basal–bolus insulin therapy; Continuous glucose monitoring; Hypoglycemia; Type 1 diabetes mellitus; Insulin degludec; Insulin glargine or detemir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：461 / 472
页数：11
相关论文
共 50 条
  • [31] Treatment satisfaction, safety, and effectiveness of biosimilar insulin glargine is comparable in patients with type 2 diabetes mellitus after switching from insulin glargine or insulin degludec: a post-marketing safety study
    Taki, Kentaro
    Koyanagi, Momoha
    Nagaoka, Soshi
    Shingaki, Tomotaka
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (12) : 1975 - 1983
  • [32] Newer basal insulin analogues: Degludec, Detemir, Glargine
    Kalra, Sanjay
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (11) : 1442 - 1444
  • [33] Costs analysis of type 2 diabetes mellitus treatment with insulin glargine or detemir
    Alvarez Guisasola, F.
    Mauricio Puente, D.
    Garcia Coscolin, T.
    Betegon Nicolas, L.
    Rubio-Terres, C.
    [J]. AVANCES EN DIABETOLOGIA, 2010, 26 (06): : 430 - 435
  • [34] A meta-analysis of clinical therapeutic effect of insulin glargine and insulin detemir for patients with type 2 diabetes mellitus
    Zhuang, Y. G.
    Peng, H.
    Huang, F.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (19) : 2566 - 2570
  • [35] Clinical and financial outcomes of switching insulin glargine to insulin detemir in a veteran population with type 2 diabetes
    Asias, Bernadette D.
    Stock, Eileen M.
    Small, Nancy L.
    Getchell, Katerine E.
    Patel, Jagruti R.
    Krause, Jennifer D.
    Cavness, Staci
    Dzenowski, Cassidy L.
    Ta, Mia
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2015, 14
  • [36] Comparative study of annual treatment costs of glargine insulin and detemir insulin in patients with type 2 diabetes mellitus in Spain
    Alvarez Guisasola, F.
    Casal LLorente, C.
    Rubio-Terrés, C.
    Betegon, L.
    Echevarria, A.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A267 - A267
  • [37] COMPARATIVE STUDY OF ANNUAL TREATMENT COST OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Sil, M. J. S. A.
    Acevedo, G. A. R.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A507 - A507
  • [38] Medium-term effects of insulin degludec on patients with type 1 diabetes mellitus
    Nakae R.
    Kusunoki Y.
    Katsuno T.
    Tokuda M.
    Akagami T.
    Murai K.
    Hamaguchi T.
    Miyagawa J.-I.
    Namba M.
    [J]. Drugs in R&D, 2014, 14 (2) : 133 - 138
  • [39] An observational study of diabetes outpatients switching from glargine or detemir to degludec
    Sato, Miki
    Shimoda, Seiya
    Sekigami, Taiji
    Motoshima, Hiroyuki
    Yoshimura, Ryohei
    Fukuda, Kazuki
    Matsuo, Yasuto
    Okubo, Mina
    Ichimori, Shinji
    Fujisawa, Kazuo
    Araki, Eiichi
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S97 - S97
  • [40] Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy
    Pieber, T. R.
    Treichel, H- C.
    Hompesch, B.
    Philotheou, A.
    Mordhorst, L.
    Gall, M- A.
    Robertson, L. I.
    [J]. DIABETIC MEDICINE, 2007, 24 (06) : 635 - 642
12345